After this study, CRISPR/Cas-9-mediated correction of FUS H517Q mutation showed that the abnormal activation of mitogen-activated protein kinase (MAPK) signaling is related to FUS mutation-mediated neurodegenerative process in ALS [142]. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.